Announcement under Regulation 30 (LODR) - Newspaper Publication for BM held on 27.05.2026
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medicamen Biotech Ltd has published its audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. The Board of Directors approved these results at their meeting held on May 27, 2026. The results were published in Financial Express and Jansatta newspapers dated May 28, 2026. The detailed financial figures including revenue, profit, and earnings per share are not included in this newspaper publication notice. The complete financial statements have been posted on the company website www.medicamen.com. This is a mandatory regulatory filing under SEBI (LODR) Regulations.
This is a routine regulatory filing announcing Q4 and full-year FY2025-26 results. The actual financial numbers are not visible in this document. Shareholders should refer to the full results posted on the company website or the detailed newspaper publication for specific performance metrics.